Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1936 1
1946 2
1947 3
1948 2
1949 1
1954 1
1955 2
1961 1
1962 3
1966 1
1967 1
1969 3
1972 1
1973 6
1974 7
1975 6
1976 3
1977 4
1978 6
1979 2
1980 6
1981 2
1982 3
1983 6
1984 3
1985 4
1986 2
1987 3
1989 1
1990 4
1991 1
1992 4
1993 1
1995 4
1996 3
1998 2
1999 3
2000 1
2001 3
2002 6
2003 1
2004 10
2005 7
2006 6
2007 11
2008 10
2009 8
2010 12
2011 12
2012 12
2013 15
2014 17
2015 16
2016 8
2017 14
2018 14
2019 18
2020 10
2021 16
2022 17
2023 24
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

341 results

Results by year

Filters applied: . Clear all
Page 1
Multiple sclerosis progression: time for a new mechanism-driven framework.
Kuhlmann T, Moccia M, Coetzee T, Cohen JA, Correale J, Graves J, Marrie RA, Montalban X, Yong VW, Thompson AJ, Reich DS; International Advisory Committee on Clinical Trials in Multiple Sclerosis. Kuhlmann T, et al. Lancet Neurol. 2023 Jan;22(1):78-88. doi: 10.1016/S1474-4422(22)00289-7. Epub 2022 Nov 18. Lancet Neurol. 2023. PMID: 36410373 Free PMC article. Review.
Edoxaban versus warfarin in patients with atrial fibrillation.
Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators. Giugliano RP, et al. N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19. N Engl J Med. 2013. PMID: 24251359 Free article. Clinical Trial.
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Störk S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S; COMPASS Investigators. Eikelboom JW, et al. N Engl J Med. 2017 Oct 5;377(14):1319-1330. doi: 10.1056/NEJMoa1709118. Epub 2017 Aug 27. N Engl J Med. 2017. PMID: 28844192 Free article. Clinical Trial.
Tff2 defines transit-amplifying pancreatic acinar progenitors that lack regenerative potential and are protective against Kras-driven carcinogenesis.
Jiang Z, Wu F, Laise P, Takayuki T, Na F, Kim W, Kobayashi H, Chang W, Takahashi R, Valenti G, Sunagawa M, White RA, Macchini M, Renz BW, Middelhoff M, Hayakawa Y, Dubeykovskaya ZA, Tan X, Chu TH, Nagar K, Tailor Y, Belin BR, Anand A, Asfaha S, Finlayson MO, Iuga AC, Califano A, Wang TC. Jiang Z, et al. Among authors: finlayson mo. Cell Stem Cell. 2023 Aug 3;30(8):1091-1109.e7. doi: 10.1016/j.stem.2023.07.002. Cell Stem Cell. 2023. PMID: 37541213
LETTER FROM THE GUEST EDITOR.
Finlayson M. Finlayson M. Int J MS Care. 2023 Nov-Dec;25(6):vi. doi: 10.7224/1537-2073-25.6.vi. Epub 2023 Nov 8. Int J MS Care. 2023. PMID: 37969908 Free PMC article. No abstract available.
Why theory matters.
Finlayson M. Finlayson M. Can J Occup Ther. 2007 Oct 4;74(4):291. doi: 10.1177/000841740707400401. Can J Occup Ther. 2007. PMID: 18051246 No abstract available.
Falls, aging, and disability.
Finlayson ML, Peterson EW. Finlayson ML, et al. Phys Med Rehabil Clin N Am. 2010 May;21(2):357-73. doi: 10.1016/j.pmr.2009.12.003. Phys Med Rehabil Clin N Am. 2010. PMID: 20494282 Review.
Modulation of CD44 Activity by A6-Peptide.
Finlayson M. Finlayson M. Front Immunol. 2015 Mar 30;6:135. doi: 10.3389/fimmu.2015.00135. eCollection 2015. Front Immunol. 2015. PMID: 25870596 Free PMC article. Review.
Crossing the threshold, finding a balance.
Finlayson M. Finlayson M. Can J Occup Ther. 2008 Apr;75(2):67-8. doi: 10.1177/000841740807500201. Can J Occup Ther. 2008. PMID: 18510250 English, French. No abstract available.
Generation and persistence of human tissue-resident memory T cells in lung transplantation.
Snyder ME, Finlayson MO, Connors TJ, Dogra P, Senda T, Bush E, Carpenter D, Marboe C, Benvenuto L, Shah L, Robbins H, Hook JL, Sykes M, D'Ovidio F, Bacchetta M, Sonett JR, Lederer DJ, Arcasoy S, Sims PA, Farber DL. Snyder ME, et al. Among authors: finlayson mo. Sci Immunol. 2019 Mar 8;4(33):eaav5581. doi: 10.1126/sciimmunol.aav5581. Sci Immunol. 2019. PMID: 30850393 Free PMC article.
341 results